Hydroxyprogesterone Caproate Injection (Makena) and Mogamulizumab
Determining the interaction of Hydroxyprogesterone Caproate Injection (Makena) and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyprogesterone
Brand name: Makena, Makena Auto-Injector, Hylutin, Delta-Lutin, Duralutin, Hyprogesterone, Prodrox
Synonyms: Hydroxyprogesterone injection, Hydroxyprogesterone Caproate
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyprogesterone Caproate Injection (Makena)-Mogamulizumab-kpkc
- Hydroxyprogesterone Caproate Injection (Makena)-Mogamulizumab-kpkc Intravenous
- Hydroxyprogesterone Caproate Injection (Makena)-Molindone
- Hydroxyprogesterone Caproate Injection (Makena)-Mometasone (Oral Inhalation)
- Hydroxyprogesterone Caproate Injection (Makena)-Mometasone and Formoterol
- Hydroxyprogesterone Caproate Injection (Makena)-Mometasone and formoterol Inhalation
- Mogamulizumab-Hydroxyprogesterone injection
- Mogamulizumab-Hydroxyprogesterone Intramuscular
- Mogamulizumab-Hydroxyquinoline vaginal
- Mogamulizumab-Hydroxyurea
- Mogamulizumab-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Mogamulizumab-Hydroxyurea Capsules 500 mg